Acadia Pharmaceuticals Inc
ACAD· Nasdaq
ACADAcadia Pharmaceuticals Inc
Released Nov 4, 2020, after the close
10-Q filed Nov 4, 2020, 35 days after period end · 0001564590-20-050566
| Metric | Q3 2020 | Q3 2019 | Q3 2018 | Q3 2017 |
|---|---|---|---|---|
| Revenue | $120.58M | $94.59M | $58.31M | $35.58M |
| Net Income | -$84.66M | -$41.98M | -$62.14M | -$65.25M |
| EPS Diluted |
Acadia Pharmaceuticals Inc · CIK 1070494 · Engraved from SEC EDGAR
| -$0.05 |
| -$0.29 |
| -$0.50 |
| -$0.53 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
